235 related articles for article (PubMed ID: 21825115)
1. Progesterone receptor membrane component 1 modulates human cytochrome p450 activities in an isoform-dependent manner.
Oda S; Nakajima M; Toyoda Y; Fukami T; Yokoi T
Drug Metab Dispos; 2011 Nov; 39(11):2057-65. PubMed ID: 21825115
[TBL] [Abstract][Full Text] [Related]
2. Progesterone receptor membrane component 1 inhibits the activity of drug-metabolizing cytochromes P450 and binds to cytochrome P450 reductase.
Szczesna-Skorupa E; Kemper B
Mol Pharmacol; 2011 Mar; 79(3):340-50. PubMed ID: 21081644
[TBL] [Abstract][Full Text] [Related]
3. Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli.
Yamazaki H; Nakamura M; Komatsu T; Ohyama K; Hatanaka N; Asahi S; Shimada N; Guengerich FP; Shimada T; Nakajima M; Yokoi T
Protein Expr Purif; 2002 Apr; 24(3):329-37. PubMed ID: 11922748
[TBL] [Abstract][Full Text] [Related]
4. S2R(Pgrmc1): the cytochrome-related sigma-2 receptor that regulates lipid and drug metabolism and hormone signaling.
Ahmed IS; Chamberlain C; Craven RJ
Expert Opin Drug Metab Toxicol; 2012 Mar; 8(3):361-70. PubMed ID: 22292588
[TBL] [Abstract][Full Text] [Related]
5. Effects of freezing, thawing, and storing human liver microsomes on cytochrome P450 activity.
Pearce RE; McIntyre CJ; Madan A; Sanzgiri U; Draper AJ; Bullock PL; Cook DC; Burton LA; Latham J; Nevins C; Parkinson A
Arch Biochem Biophys; 1996 Jul; 331(2):145-69. PubMed ID: 8660694
[TBL] [Abstract][Full Text] [Related]
6. Interactions of mammalian cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b(5) enzymes.
Shimada T; Mernaugh RL; Guengerich FP
Arch Biochem Biophys; 2005 Mar; 435(1):207-16. PubMed ID: 15680923
[TBL] [Abstract][Full Text] [Related]
7. Dap1/PGRMC1 binds and regulates cytochrome P450 enzymes.
Hughes AL; Powell DW; Bard M; Eckstein J; Barbuch R; Link AJ; Espenshade PJ
Cell Metab; 2007 Feb; 5(2):143-9. PubMed ID: 17276356
[TBL] [Abstract][Full Text] [Related]
8. Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes.
Yamazaki H; Nakano M; Imai Y; Ueng YF; Guengerich FP; Shimada T
Arch Biochem Biophys; 1996 Jan; 325(2):174-82. PubMed ID: 8561495
[TBL] [Abstract][Full Text] [Related]
9. In vitro inhibition of SKOV-3 cell migration as a distinctive feature of progesterone receptor membrane component type 2 versus type 1.
Albrecht C; Huck V; Wehling M; Wendler A
Steroids; 2012 Dec; 77(14):1543-50. PubMed ID: 23064006
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of time-dependent cytochrome P450 inhibition using cultured human hepatocytes.
McGinnity DF; Berry AJ; Kenny JR; Grime K; Riley RJ
Drug Metab Dispos; 2006 Aug; 34(8):1291-300. PubMed ID: 16679385
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and metabolism of a cysteinyl leukotriene-1 receptor antagonist from the heterocyclic chromanol series in rats: in vitro-in vivo correlation, gender-related differences, isoform identification, and comparison with metabolism in human hepatic tissue.
Kuperman AV; Kalgutkar AS; Marfat A; Chambers RJ; Liston TE
Drug Metab Dispos; 2001 Nov; 29(11):1403-9. PubMed ID: 11602515
[TBL] [Abstract][Full Text] [Related]
12. Chlorzoxazone metabolism by porcine cytochrome P450 enzymes and the effect of cytochrome b5.
Wiercinska P; Squires EJ
Drug Metab Dispos; 2010 May; 38(5):857-62. PubMed ID: 20164110
[TBL] [Abstract][Full Text] [Related]
13. Electron shuttle between membrane-bound cytochrome P450 3A4 and b5 rules uncoupling mechanisms.
Perret A; Pompon D
Biochemistry; 1998 Aug; 37(33):11412-24. PubMed ID: 9708976
[TBL] [Abstract][Full Text] [Related]
14. Interaction of cisapride with the human cytochrome P450 system: metabolism and inhibition studies.
Desta Z; Soukhova N; Mahal SK; Flockhart DA
Drug Metab Dispos; 2000 Jul; 28(7):789-800. PubMed ID: 10859153
[TBL] [Abstract][Full Text] [Related]
15. Progesterone receptor membrane component 1 (PGRMC1) binds and stabilizes cytochromes P450 through a heme-independent mechanism.
McGuire MR; Mukhopadhyay D; Myers SL; Mosher EP; Brookheart RT; Kammers K; Sehgal A; Selen ES; Wolfgang MJ; Bumpus NN; Espenshade PJ
J Biol Chem; 2021 Nov; 297(5):101316. PubMed ID: 34678314
[TBL] [Abstract][Full Text] [Related]
16. Effects of chronic exposure to cadmium on renal cytochrome P450-dependent monooxygenase system in rats.
Plewka A; Plewka D; Nowaczyk G; Brzóska MM; Kamiński M; Moniuszko-Jakoniuk J
Arch Toxicol; 2004 Apr; 78(4):194-200. PubMed ID: 14595535
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of CYP2E1 catalytic activity in vitro by S-adenosyl-L-methionine.
Caro AA; Cederbaum AI
Biochem Pharmacol; 2005 Apr; 69(7):1081-93. PubMed ID: 15763544
[TBL] [Abstract][Full Text] [Related]
18. PGRMC1 (progesterone receptor membrane component 1): a targetable protein with multiple functions in steroid signaling, P450 activation and drug binding.
Rohe HJ; Ahmed IS; Twist KE; Craven RJ
Pharmacol Ther; 2009 Jan; 121(1):14-9. PubMed ID: 18992768
[TBL] [Abstract][Full Text] [Related]
19. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.
Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP
Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808
[TBL] [Abstract][Full Text] [Related]
20. Identification of the main human cytochrome P450 enzymes involved in safrole 1'-hydroxylation.
Ueng YF; Hsieh CH; Don MJ; Chi CW; Ho LK
Chem Res Toxicol; 2004 Aug; 17(8):1151-6. PubMed ID: 15310247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]